Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
261. |
ECCT/19/11/03 | A Pilot BE study for Enalpril 5mg A bioequivalent pilot study of a locally-produced brand of enalapril tablets: a key step towards implementation of bioequivalent study regulatory requirements in East Africa |
Principal Investigator(s) 1. Simon Njoroge Njenga Site(s) in Kenya Kenya Medical Research Institute |
View |
262. |
ECCT/19/11/04 | Second line switch to Dolutegravir (2SD) study Switching Treatment-Experienced, Integrase Inhibitor-Naïve, Virally Suppressed HIV-1 Infected Adults from Ritonavir boosted Protease Inhibitors to Dolutegravir: An Open-Label Randomized Controlled Trial |
Principal Investigator(s) 1. Loice Achieng Site(s) in Kenya 1. Kenyatta National Hospital (Nairobi City county) 2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county) 3. Thika Level 5 Hospital (Kiambu county) 4. Kiambu Level 5 Hospital (Kiambu county) |
View |
263. |
ECCT/19/11/02 | PrEP and dPEP PrEP and dPEP: Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis |
Principal Investigator(s) 1. Dr.Elizabeth Bukusi Ann Bukusi Site(s) in Kenya KEMRI/CMR/RCTP Kisumu-Lumumba Sub-County Hospital |
View |
264. |
ECCT/19/12/01 | BOHEMIA PK400 Mosquitocidal effect and pharmacokinetics of different ivermectin dose regimens in preparation for BOHEMIA cluster randomized controlled trial. |
Principal Investigator(s) 1. Marta Ferreira Maia Site(s) in Kenya Kilifi |
View |
265. |
ECCT/19/10/03 | Smoking Cessation Study for PLHIV Optimizing Smoking Cessation Interventions For People Living With Human Immunodeficiency Virus in Nairobi, Kenya |
Principal Investigator(s) 1. Dr. Seth Scott Himelhoch Seth Scott Himelhoch Site(s) in Kenya Mathari National Teaching and Referral Hospital |
View |